Gallbladder neuroendocrine carcinoma diagnosis, treatment and prognosis based on the SEER database: A literature review

Table 5 Currently effective chemoradiotherapy regiments that have been tried

Ref.	Chemoradiotherapy regiments
Moris et al[44]	XELOX and Zometaf
Chen et al[36], Meoni et al[45], Furrukh et al[46], Abutaka et al[49]	CBP and ETP
Tidjane et al[39]	ETP+CP four cycles + 5-fluorouracil + oxaliplatin
Okuyama et al[34]	Intravenous CP (60 mg/m2) and DXT (60 mg/m2) every 3 wk for four cycles, followed by intravenous CBP (120 mg/m2) and DXT (60 mg/m2) every 3 wk for three cycles
Duffy et al[3]	VP-16 150 mg/dL; CP 50 mg/dL
Chen et al[4]	Radiotherapy with 10 MV-X-ray and 3D-CRT, (50 Gy/25f)
Shimono et al[10]	3D-CRT (40 Gy/20 fractions per 4 wk and to give 10 Gy/20 fractions per 4 wk, respectively, resulting in a total dose of 50 Gy) + CP + ETP and CAV followed by CP + ETP alone
Shimono et al[10]	Three cycles of CP (50 mg/body) + ETP (80 mg/body) as systemic chemotherapy

CBP: Carboplatin; ETP: Etoposide (VP-16); CP: Cisplatin; 3D-CRT: 3D conformal radiotherapy; DXT: Docetaxel; CAV: Etoposide; cyclophosphamide, adriamycin, and vincristine.